Pfizer reaches multi-year agreement with Gilead to manufacture remdesivir to treat COVID-19

Pfizer Inc announced on Friday that it reached a multi-year agreement with Gilead Sciences to manufacture and supply Gilead's investigational antivira
อ่านเพิ่มเติม Previous